Cancer can develop in any organ of the urinary system and the male reproductive system. These are known as urologic cancers and include bladder, kidney, penile, prostate and testicular cancers. The earlier a urologic cancer is detected, the greater the chance of successful treatment. At Penn Medicine, cancers are treated by our team of specialists and clinicians within the Abramson Cancer Center. 

  • Bladder Cancer - Along with minimally invasive bladder-sparing treatments, Penn urologists have experience in creating an "intestinal bladder" for patients in whom the bladder is removed.
  • Kidney Cancer - Penn urologists have a wealth of experience in managing kidney cancer, with an emphasis on sparing the kidney whenever possible.
  • Penis/Urethra Cancer - At Penn Urology, we have care providers specially trained in the diagnosis and management of these uncommon tumors.
  • Prostate Cancer - Prostate cancer is among the most common cancers in American men. All of the latest advances in the treatment of prostate cancer are available at Penn.
    A personalized treatment plan is developed for each patient based on his needs, which may include:
    • Traditional, nerve-sparing prostatectomy.
    • Robotic, nerve-sparing prostatectomy.
    • Radiation therapy for prostate cancer including:
      • Proton therapy
      • Intensity-modulated radiation therapy (IMRT)
      • Image guided radiation therapy
      • Cyberknife®
    • Brachytherapy, in which radioactive seeds are placed (implanted) into the prostate in the
      operating room.
  • Testis Cancer - In younger men (ages 15 to 45), testicular cancer is the most common form of urologic cancer. Penn urologists are experienced in the latest techniques and protocols for treating this serious disease.
Share This Page: